(Press-News.org) Nice, 13 June 2012: New scientific findings in anticoagulation for stroke prevention are paving the way for updates to the European Society of Cardiology (ESC) Guidelines for the management of atrial fibrillation.
Some of these findings were presented during the European Heart Rhythm Association (EHRA) sessions at Cardiostim 2012, 13-16 June, in Nice, France. Cardiostim is an international scientific congress in the field of electrophysiology and cardiac techniques. It is organised in collaboration with the ESC and EHRA, which is a registered branch of the ESC. Link to Cardiostim
Experts from EHRA showcased the latest science in electrophysiology and cardiac techniques during 30 EHRA sessions at Cardiostim. Professor Gregory YH Lip (Birmingham, UK) and other EHRA members presented the most up to date findings in the field of anticoagulation for stroke prevention in atrial fibrillation.
The CHA2DS22-VASc score to assess stroke risk has now been validated in different independent populations. "The CHA2DS2-VASc score outperforms other stroke risk scores including the older CHADS2 score in identifying very low risk patients who do not need any antithrombotic therapy," says Professor Lip. "And in some of the validations the CHA2DS2-VASc score outperforms the CHADS2 score in predicting those who get a stroke subsequently."
In the past, patients with a CHADS2 score of 0 were considered to be at low risk of stroke. But when these patients were substratified using the CHA2DS2-VASc score, these patients had stroke rates between 0.8-3.2% per year, if untreated (1). Professor Lip says: "Thus, those patients with a CHADS2 score of 0 are not low risk at all and show that the CHADS2 score does not accurately define low risk patients."
A net clinical benefit analysis balancing ischaemic stroke against intracranial bleeding based on a dataset of more than 180,000 patients with atrial fibrillation in Sweden found that patients with a CHA2DS2-VASc score >1 had a positive net clinical benefit when they were anticoagulated. The findings were irrespective of bleeding risk, which was assessed by the HAS-BLED score (2).
The effectiveness of the HAS-BLED score in assessing major bleeding risk (and the risk of intracranial haemorrhage) has been confirmed in numerous cohorts of patients with atrial fibrillation who are taking oral anticoagulation (3). The score also predicted cardiovascular events and mortality. Professor Lip says: "Recent data also shows that the HAS-BLED score also outperforms other scores (both new and old ones) in predicting bleeding risk."
These new findings support the moves in the 2010 ESC Guidelines for the management of atrial fibrillation to introduce the HAS-BLED bleeding score, and to shift away from the traditional low/moderate/high risk artificial categorisation of stroke risk, and moving towards a risk factor based approach to stroke prevention in atrial fibrillation using the CHA2DS2-VASc score.
Novel data has also been published on the new oral anticoagulants for stroke prevention in atrial fibrillation. In a recent modelling analysis, the researchers used the scores for stroke risk and bleeding to calculate the net clinical benefit of the new anticoagulants. They found that when the risk of bleeding and stroke were both high, the new oral anticoagulants appeared to have a much greater net clinical benefit compared to warfarin (4).
"Since 2010 there have many new trials related to the new anticoagulants and therefore this is a very exciting time for stroke prevention," says Professor Lip. "These new drugs are powerful anticoagulants. They work well if they are used correctly and in the appropriate patients."
These new findings in this fast changing field are paving the way for the launch of a Focused Update to the ESC Guidelines on atrial fibrillation at the ESC Congress in August in Munich, Germany.
Cardiostim is expected to attract more than 5,000 delegates from across the globe with an interest in electrophysiology. Future events in this field include EHRA EUROPACE 2013, which will be held 23-26 June 2013 in Athens, Greece. This conference is EHRA's official meeting and for the first time in 2013 it will be held jointly with the ESC Working Group on Cardiac Cellular Electrophysiology and the ESC Working Group on e-Cardiology. This unique partnership emphasises the multidisciplinary and translational approach in modern electrophysiology in the diagnosis and therapy of arrhythmias and conduction disturbance.
INFORMATION: END
Researchers at the University of East Anglia (UEA) have discovered unexpectedly large genetic differences between two similar species of the pathogenic Cryptosporidium parasite.
Published today in the journal Evolutionary Applications, the findings pave the way for a new gold standard test to distinguish between the waterborne parasite's two main species affecting humans. One species is spread from person to person (Cryptosporidium hominis) but the other is often spread from livestock to people (Cryptosporidium parvum).
"Being able to discriminate quickly between the ...
In a new study released today in New England Journal of Medicine, researchers demonstrate that whole genome sequencing can provide clinically relevant data on bacterial transmission within a timescale that can influence infection control and patient management.
Scientists from the Wellcome Trust Sanger Institute, University of Cambridge, and Illumina collaborated to use whole genome sequencing to identify which isolates of methicillin-resistant Staphylococcus aureus (MRSA) were part of a hospital outbreak.
Current laboratory techniques often cannot distinguish between ...
Researchers have developed a new technique to identify hotspots of malaria parasite evolution and track the rise of malarial drug resistance, faster and more efficiently than ever before.
For the first time, researchers have the ability to analyse malaria genomes straight from patient blood samples using new sequencing technologies and informatics methods. As a proof of principle, the team conducted the first analysis of clinical samples from six countries and uncovered unique differences in malaria development in Africa, Asia and Oceania. This study is published in Nature ...
VIDEO:
Astrophysicist Lars Buchhave, University of Copenhagen explains about his new research showing, that planets up to four times the size of the Earth can form around very different stars...
Click here for more information.
It had previously been thought that planets were more likely to form around a star if the star had a high content of heavier elements. But new research from the University of Copenhagen, among others, shows that small planets can form around very ...
ANCHORAGE, Alaska - Even small telescopes can make big discoveries.
Though the KELT North telescope in southern Arizona carries a lens no more powerful than a high-end digital camera, it's just revealed the existence of two very unusual faraway planets.
One planet is a massive, puffed-up oddity that could change ideas of how solar systems evolve. The other orbits a very bright star, and will allow astronomers to make detailed measurements of the atmospheres of these bizarre worlds.
Ohio State University doctoral student Thomas Beatty and Vanderbilt University research ...
DURHAM, N.C. -- The health of a caregiver is the most important predictor of orphan health, according to a new Duke University study that spans five less-wealthy nations in Africa and Asia. More important than an orphan's geographic location, living conditions or past trauma, the Duke study finds that an unhealthy caregiver likely means an unhealthy child.
The findings prompt Duke researchers to call for international orphan policies to place greater attention on assessing and treating an orphan and his caregiver's health together, rather than focusing solely on children's ...
Microbes inhabit just about every part of the human body, living on the skin, in the gut, and up the nose. Sometimes they cause sickness, but most of the time, microorganisms live in harmony with their human hosts, providing vital functions essential for human survival. For the first time, a consortium of researchers organized by the National Institutes of Health has mapped the normal microbial make-up of healthy humans, producing numerous insights and even a few surprises.
Researchers found, for example, that nearly everyone routinely carries pathogens, microorganisms ...
Boston – June 13, 2012 -- After people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. But the reason has long puzzled scientists. Now researchers at Joslin Diabetes Center have identified the misstep that sparks this runaway chronic damage and a promising way to block it.
"The problem arises from autoimmunity, a condition that people with type 1 diabetes already have ," says Myra A. Lipes, M.D, investigator in the Section on Immunology at Joslin and principal investigator of a study published in the June ...
Research into alcohol's effect on juvenile rats shows they have an ability to build up a physical, but not cognitive, tolerance over the short term — a finding that could have implications for adolescent humans, according to Baylor University psychologists.
The research findings are significant because they indicate that blood alcohol concentration levels alone may not fully account for impaired orientation and navigation ability, said Jim Diaz-Granados, Ph.D., professor and chair of psychology and neuroscience at Baylor. He co-authored the study, published in the journal ...
For the first time, scientists have defined the bacteria that inhabit multiple sites along the healthy human digestive tract in a large number of individuals. To prevent and control bacterial diseases, it is essential to first identify which bacteria are responsible for keeping us in good health. As part of the Human Microbiome Project, the Forsyth Institute-led team examined bacteria found in adults at 10 sites along the digestive tract, including seven mouth surfaces, the tonsils, the throat and stool samples. This work lays an important foundation for future research ...